<DOC>
	<DOCNO>NCT00697281</DOCNO>
	<brief_summary>The primary objective study evaluate range dose level efficacy control symptom allergic rhinitis</brief_summary>
	<brief_title>OC000459 Dose Finding Study Hay Fever Sufferers .</brief_title>
	<detailed_description>This randomise , double blind , placebo control , parallel group evaluation OC000459 give orally eight day . Four dose level study compare placebo . They study treatment group 18 21 subject . The placebo group also consist 18 21 subject . There screen period six week . There follow one three week last dose study drug .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Indoleacetic Acids</mesh_term>
	<criteria>Males female age 18 50 year history symptom grass pollen relate allergic rhinitis within previous two year . Females childbearing potential ( i.e . menstrual period within two year prior date screening ) must practise two form contraception must negative pregnancy test ( blood urine ) screening . Acceptable contraception include use TWO following : oral contraception ( i.e . Pill ) ; intrauterine device ( IUD 'Coil ' ) ; barrier contraception ( i.e . condom diaphragm/cap ) ; transdermal patch Medical condition likely affect outcome study . Nasal condition likely affect outcome study , i.e . nasal septal perforation , nasal polyp , sinus disease , chronic nasal obstruction , nasal disease determine principal investigator designee . Presence respiratory disease history mild stable asthma require treatment associate normal lung function ( define FEV1 â‰¥ 90 % predict height age ) . Immunotherapy treatment course past 28 day Use inhale local corticosteroid past 28 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>allergic rhinitis</keyword>
	<keyword>human</keyword>
	<keyword>clinical trial</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>challenge test</keyword>
</DOC>